Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment options for colorectal liver metastases.

Literature DB >> 1437919

Treatment options for colorectal liver metastases.

I Taylor¹.

Abstract

Entities: Disease

Mesh：

Year: 1992 PMID： 1437919 PMCID： PMC2399361 DOI： 10.1136/pgmj.68.800.403

Source DB: PubMed Journal: Postgrad Med J ISSN： 0032-5473 Impact factor: 2.401

× No keyword cloud information.

13 in total

Review 1. Resection of liver metastases from a colorectal carcinoma does not benefit the patient.

Authors: T M Hunt; N Carty; C D Johnson
Journal: Ann R Coll Surg Engl Date: 1990-05 Impact factor: 1.891

2. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

Authors: A E Chang; P D Schneider; P H Sugarbaker; C Simpson; M Culnane; S M Steinberg
Journal: Ann Surg Date: 1987-12 Impact factor: 12.969

3. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I).

Authors: J C Wereldsma; E D Bruggink; W S Meijer; J A Roukema; W L van Putten
Journal: Cancer Date: 1990-02-01 Impact factor: 6.860

4. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases.

Authors: T M Hunt; A D Flowerdew; S J Birch; J D Williams; M A Mullee; I Taylor
Journal: Br J Surg Date: 1990-07 Impact factor: 6.939

5. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.

Authors: N Wolmark; H Rockette; D L Wickerham; B Fisher; C Redmond; E R Fisher; M Potvin; R J Davies; J Jones; A Robidoux
Journal: J Clin Oncol Date: 1990-09 Impact factor: 44.544

6. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

Authors: J Scheele; R Stangl; A Altendorf-Hofmann
Journal: Br J Surg Date: 1990-11 Impact factor: 6.939

7. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

Authors: S Wadler; E L Schwartz; M Goldman; A Lyver; M Rader; M Zimmerman; L Itri; V Weinberg; P H Wiernik
Journal: J Clin Oncol Date: 1989-12 Impact factor: 44.544

8. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors: C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal: N Engl J Med Date: 1990-02-08 Impact factor: 91.245

9. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.

Authors: F Safi; R Bittner; R Roscher; K Schuhmacher; W Gaus; G H Beger
Journal: Cancer Date: 1989-07-15 Impact factor: 6.860

10. Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases.

Authors: J A Goldberg; J A Thomson; M S Bradnam; J Fenner; R G Bessent; J H McKillop; D J Kerr; C S McArdle
Journal: Br J Cancer Date: 1991-07 Impact factor: 7.640

2 in total

1. Increase in immunoreactivity for endothelin-1 in blood vessels of rat liver metastases: experimental sarcoma and carcinoma.

Authors: A Loesch; M Turmaine; M Loizidou; R Crowe; S Ashraf; I Taylor; G Burnstock
Journal: J Anat Date: 1997-08 Impact factor: 2.610

2. Blood vessels in liver metastases from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells.

Authors: S Ashraf; M Loizidou; R Crowe; M Turmaine; I Taylor; G Burnstock
Journal: Clin Exp Metastasis Date: 1997-09 Impact factor: 5.150

2 in total